| Authors: |
Alvarez RD; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Årdal C; Antimicrobial Resistance Centre, Norwegian Institute of Public Health, Oslo, Norway., Classen AY; Department of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany; German Centre for Infection Research, Partner site Bonn-Cologne, Germany; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Non-Traditional Antibacterial Therapy (ESGNTA)., Nagel TE; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Non-Traditional Antibacterial Therapy (ESGNTA); Phages for Global Health, Oakland, CA, USA., Ceyssens PJ; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Non-Traditional Antibacterial Therapy (ESGNTA); Unit of Human Bacterial Diseases, Sciensano, Brussels, Belgium., German GJ; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Non-Traditional Antibacterial Therapy (ESGNTA); Phage Canada, Maple, Ontario, Canada; Unity Health Toronto, St. Joseph's Health Centre and Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada. Electronic address: Gregory.German@unityhealth.to. |
